 Survival Rate
"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 0 | 9 | 9 | | 1991 | 0 | 8 | 8 | | 1992 | 0 | 7 | 7 | | 1993 | 0 | 19 | 19 | | 1994 | 0 | 17 | 17 | | 1995 | 0 | 11 | 11 | | 1996 | 0 | 9 | 9 | | 1997 | 0 | 25 | 25 | | 1998 | 0 | 18 | 18 | | 1999 | 0 | 15 | 15 | | 2000 | 0 | 21 | 21 | | 2001 | 0 | 25 | 25 | | 2002 | 0 | 28 | 28 | | 2003 | 1 | 24 | 25 | | 2004 | 0 | 25 | 25 | | 2005 | 0 | 38 | 38 | | 2006 | 0 | 46 | 46 | | 2007 | 0 | 45 | 45 | | 2008 | 0 | 53 | 53 | | 2009 | 0 | 44 | 44 | | 2010 | 1 | 61 | 62 | | 2011 | 0 | 64 | 64 | | 2012 | 1 | 48 | 49 | | 2013 | 0 | 65 | 65 | | 2014 | 1 | 79 | 80 | | 2015 | 0 | 71 | 71 | | 2016 | 1 | 63 | 64 | | 2017 | 1 | 86 | 87 | | 2018 | 1 | 66 | 67 | | 2019 | 0 | 71 | 71 | | 2020 | 0 | 11 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Madhavan M, Holmes DN, Piccini JP, Freeman JV, Fonarow GC, Hylek EM, Kowey PR, Mahaffey KW, Pieper K, Peterson ED, Chan PS, Allen LA, Singer DE, Naccarelli GV, Reiffel JA, Steinberg BA, Gersh BJ. Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF). Am J Cardiol. 2020 10 01; 132:66-71.
-
Bhatia S, Bukkapatnam S, Van Court B, Phan A, Oweida A, Gadwa J, Mueller AC, Piper M, Darragh L, Nguyen D, Gilani A, Knitz M, Bickett T, Green A, Venkataraman S, Vibhakar R, Cittelly D, Karam SD. The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme. Mol Carcinog. 2020 09; 59(9):1064-1075.
-
Iwanaga R, Truong BT, Hsu JY, Lambert KA, Vyas R, Orlicky D, Shellman YG, Tan AC, Ceol C, Artinger KB. Loss of prdm1a accelerates melanoma onset and progression. Mol Carcinog. 2020 09; 59(9):1052-1063.
-
Torphy RJ, Fujiwara Y, Schulick RD. Pancreatic cancer treatment: better, but a long way to go. Surg Today. 2020 Oct; 50(10):1117-1125.
-
Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C, Mattu A, Kirtane AJ, Jauhar R, Meraj P, Rokos IC, Rumsfeld JS, Henry TD. Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Catheter Cardiovasc Interv. 2020 08; 96(2):336-345.
-
Mansfield SA, Lamb MG, Stanek JR, Arnold MA, Ranalli M, Aldrink JH. Renal Tumors in Children and Young Adults Older Than 5 Years of Age. J Pediatr Hematol Oncol. 2020 05; 42(4):287-291.
-
Dagan A, Choudhury RA, Yaffe H, Yoeli D, Moore HB, Conzen KD, Adams M, Wachs M, Pomposelli JJ, Pomfret EA, Nydam TL. Offspring Versus Nonoffspring to Parent Living Donor Liver Transplantation: Does Donor Relationship Matter? Transplantation. 2020 05; 104(5):996-1002.
-
Choudhury R, Barrett CD, Moore HB, Moore EE, McIntyre RC, Moore PK, Talmor DS, Nydam TL, Yaffe MB. Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis. World J Emerg Surg. 2020 04 20; 15(1):29.
-
Stein EM, Fathi AT, DiNardo CD, Pollyea DA, Roboz GJ, Collins R, Sekeres MA, Stone RM, Attar EC, Frattini MG, Tosolini A, Xu Q, See WL, MacBeth KJ, de Botton S, Tallman MS, Kantarjian HM. Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial. Lancet Haematol. 2020 Apr; 7(4):e309-e319.
-
Bababekov YJ, Hung YC, Chang DC, Rickert CG, Adler JT, Bethea E, Pomfret EA, Pomposelli JJ, Yeh H. Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease? Transplantation. 2020 02; 104(2):280-284.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|